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INTRODUCTION
Cancer initiation requires tumor cells to obtain several key traits, such as sustained proliferative signaling, resistance to cell death, and accelerated cell growth leading to a competitive advantage over slow-growing neighboring cells (1, 2) . Accelerated proliferation of cancer cells inevitably increases their underlying rate of mutations (2, 3) , copy number variations (CNVs) that affect a larger fraction of cancer genomes (4) (5) (6) (7) . It has been shown that positive selected CNVs (drivers) have critical roles in activating oncogenes and in inactivating tumor suppressors (6, (8) (9) (10) (11) (12) (13) (14) . While many other mutations, including CNVs, may be fitness-neutral and are termed passenger mutations (15, 16) , there in fact exist a larger class of mutations that reduce cancer cell proliferation and slow cell growth (17, 18) . This class of deleterious mutations has been referred to as "negative drivers" (18) .
Deleterious mutations cannot be efficiently purged by natural selection in populations with no recombination. The phenomenon is referred to as Muller's ratchet, a moving mechanism that is used to indicate the irreversible accumulation of deleterious mutations (19, 20) . Since recombination, which can enhance the efficacy of selection against deleterious mutations (20, 21) , is absent in the clonally-reproducing cancer cells, accumulation of deleterious mutations can collectively exert a noticeable effect on fitness (22) . Deleterious mutations may have a variety of effects on tumorigenesis by shaping cancer growth and intra-tumor variation.
If the incidence of deleterious mutations is low or negligible, cancer progression can be easily described by relatively simple mathematical models and genetic variation within tumors can be treated as a function of population size. At another extreme, if deleterious mutations are prevalent, the majority of cancer cells would be defect with limited proliferative ability and only a small fraction of cells in a tumor would be capable of constantly dividing. Accordingly, the proportion and the effect size distributions of deleterious mutations must not be overlooked and may be key parameters to model tumorigenesis.
Guided by previous experience in population genetics, most studies in cancer focus on slightly deleterious mutations as they should be able to evade purifying selection and accumulate, thus influencing long-term tumor progression (23) . Because highly deleterious mutations should be rapidly weeded out by purifying selection, it is generally assumed that these mutations have little to do with long-term cancer progression.
Thus, the most common mutations, either fixed or at high frequency, that are frequently cited in cancer 4 genomic studies are usually advantageous for individual cell fitness. Such practical limitations ensure that deleterious mutations are mostly undetected in empirical studies. Indeed, even the relatively comprehensive TCGA pan-cancer data set yielded only a small number of deleterious mutations, highlighting gaps in our knowledge about this important class of variants (18) .
Direct measurements of individual deleterious mutation effects in vivo are challenging. However, an assessment of their collective action is possible, given a system that generates such variants at an appreciable rate. HeLa cells present such as system as their genomes are highly variable. In addition, this cell line has attractive features for our purposes since it has been extensively cultured and exhibits a short doubling time and aggressive growth. We examined variation in growth rate among individual HeLa cells by monitoring clones from a common ancestral HeLa cell population. We then estimated deleterious mutation rate and the average fitness decrease per mutation by performing computer simulations of cell growth. Our observations suggest that the differences in growth rate among cell clones are heritable, and CNV is the major cause of proliferative fitness reduction in HeLa cells. HeLa cells constantly produce high numbers of deleterious mutations during growth. We discuss the implications of our findings for modeling tumorigenesis.
RESULTS

Genetic variation in growth rate in a HeLa cell population
To ensure genomic homogeneity of the initial population, we first established a HeLa cell line (E6) derived from an ancestral cell line (JF) (Fig. S1) . When E6 population size reached approximately 5 × 10 4 cells (15~16 divisions), five single-cell clones were generated from E6 and established in culture. When the clone cultures reached 10 6 ~ 10 7 cells, we measured their growth rates using the MTT assay. The B8 and G3 clones showed clearly higher growth rates than E3, E7 and G2, suggesting that cells within E6 were heterogeneous (Fig. 1A ).
Since these clones were all descendants of E6 which originated from a single cell and experienced only 15 -16 divisions, our results indicate that heterogeneity in growth rate can be generated in a very short period of time in cancer cells.
To test whether variation in growth rate among clones is heritable, we isolated 39 cells from B8 (fast growing clone) and 40 cells from E3 (slow growing clone), and monitored their growth from a single cell for seven days. Approximately 30% of B8 and 50% of E3 cells died out within seven days (Fig. S2 ), due to either 5 damage caused during cell isolation or genetic defects. Furthermore, most cell lines with growth rates < 0.6 died within 2 months. Thus, only 50% of B8 and 27% of E3 cells survived for more than two months.
While the growth rates of cells from a single origin varied greatly, the progeny of the fast-growing clone (B8) grew faster on average than those of the slow growing clone (E3) ( Fig. 1B) . Mean cell number among the B8 progeny was 62.0, while it was 17.3 among E3-derived cell lines. We further drew approximately 100 cells from one fast-(progeny D) and one slow-(progeny C) (Fig. S2 ) growing derivative of B8 and monitored growth of each cell clone for seven days. As expected, cells from the fast-growing progeny had a higher mean growth rate than that from the slow-growing descendant (p = 2 x 10 -11 , KS test; Fig. 1C ).
If mutations that slow cell proliferation frequently arise in cancerous cell populations, we would expect a decrease in proliferation rates and an increase in among-cell growth speed variance as the population is maintained. To test this, we monitored growth of single cells that were randomly drawn from cell populations at different time points. We first set up six single-cell clones from B8 (Table S1 ). After cell numbers reached 100 -500 (8-10 cell divisions), 20 -30 % of the cells from each population were randomly drawn and separated into single cells. The growth of these isolates was monitored for eight days. This step was repeated when the size of the six populations exceeded 5,000 cells. In all six cases, the average growth rate of cells drawn at the first time point was higher than those from the second time point (Fig. S3 ). In addition, in four out of six cases, variation in growth rate was higher at the second than at the first time point (t-test).
To test whether the slow-growing cells would be outcompeted by their fast-growing counterparts, we performed a competition assay. The fast-and slow-dividing cells were co-cultured in different ratios and their proportions in populations were monitored weekly using the Discosoma sp. red fluorescence protein (DsRed) and enhanced green fluorescence protein (eGFP) over time using flow cytometry. We ran the experiment for eight weeks. Regardless of the initial proportions, the fast-dividing cells always outgrew the slow-dividing cells in our co-culture assays over time ( Fig. 1D and E), suggesting that fast cells indeed possessed higher fitness than the slow ones. Fig. 1 demonstrates that a cancer cell population can generate heterogeneity in growth rate within several cell replications, even starting from a single cell. Moreover, the majority of these changes is heritable and reduces the fitness of cancer cells (defined as proliferation rate), suggesting that fitness reduction we observe is largely genetically determined.
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Cell growth rate is associated with CNV number
To study the genetic basis of growth rate heterogeneity among our cancer cell lines, we assessed genomic variation in E6 and five of its descendant clones by constructing a digital copy-number profile based on next generation sequencing reads. We focused on copy number variation because single-nucleotide mutation rates are too slow to produce significant sequence variation during our short-duration culturing experiments. Most clone genomes are triploid (Fig. S4) , and only a small number harbors more than four or fewer than two haploid genomes, consistent with a previous study (24) .
The three slow-growing clones showed a clear increase in CNV copy number compared to the E6 parental line (Fig. 2 , Table S2 ), while the two fast-growing clones were more similar to E6, suggesting that that most CNVs are deleterious. As E6 experienced only 15 -16 divisions before its five descendant clones were generated, above results also indicate that CNVs can be generated in a very short period of time. To test this hypothesis, 11 clones derived from B8 with different growth rates between day 1 to 8 were picked for further analyses (Fig. 3A) . The growth rate of each clone was measured again by RTCA iCELLigence when the 
Rate of deleterious mutations
To further study how fast the difference in proliferation rate can be generated, we picked 12 cells from B8, allowed them to divide once, and isolated each daughter cell in a well of a 96-well plate. We then monitored the growth of each of the 12 pairs of cells for four days (Fig. 4A ). Four cell pairs lost at least one of the daughters in the first four days, probably due to injury during preparation. Of the remaining eight pairs, two (h and i, Fig. 4A ) exhibited different proliferation rates between the daughter cell lineages. The result suggests that there is approximately one deleterious mutation in every four cell divisions in this cancer cell line.
Such a high deleterious mutation rate implies that many cells at day four would carry deleterious mutations which reduce cell proliferation. To test this, each descendant of clone f was harvested and resuspended into a 96-well plate. We monitored growth of these progeny for another four days. As expected, the majority of the surviving clones exhibited slower growth than their ancestor f (Fig. 4B ).
Modeling population growth attenuation
Rough estimates from our experiments so far suggest extremely high mutation rates in cancer cell lines. To understand mutation accumulation rates in tumors, we need quantitative estimates of deleterious mutation rates and effect distributions. Therefore, we constructed and applied a simple model of cell growth and the mutation accumulation process (see Materials and Methods). Let Nt be the population size at day t, where N0 = 1, and Rt be the population growth rate at day t. For each generation, a proportion of cells (μ) generates new mutations which decrease their growth rate. The mean deleterious effect of a mutation is d. We have
where R0 is the net growth rate at day 0.
To estimate parameters of this model (R0, μ, and d) we randomly drew 18 single cells from B8 and monitored their growth for 7-8 days (Table S3) . We divided these newly-derived cell lines into fast-(cell number > 100) and slow-growing (cell number < 100) groups. We then conducted computer simulations to evaluate the parameters that best fit the observed data (see Materials and Methods).
Using fast-growing cell data, we estimate posterior mean of R0 = 2.37 ( (Table S3 ). Using point estimates of μ (0.29) and d (0.18), we fitted our model to the growth rates observed in a range of experimental data ( Fig. S2 ) and estimated initial growth rates (R0). Only cell lines that showed monotonic increase in cell numbers were considered. The estimation of R0 , ranging from 1.64 to 2.54 in 43 sets of experimental data ( 
Discussion
We performed multiple single-cell progeny assays using HeLa cell lines and extensively genotyped the clonal populations, focusing on copy number variants (CNVs). We fitted a growth model to these data to estimate distributions of mutation effects on fitness as measured by proliferative capacity. We show that CNV deleterious mutations appear at the rate that falls in the range of 0. (17, 27) . While at first this may seem to be unreasonably high, the mutations we identified would not be seen in cancer cell populations within tumors as the vast majority of these variants are too deleterious to appear in the earlier data sets. Nevertheless, the observation that a significant portion of cancerous cells are born with a low enough proliferative capacity that they are rapidly lost during tumor growth suggests that there is a trade-off between cancer progression and genome instability. While cancer cells may benefit from generating genetic variation paving the way for tumor progression, accumulation of deleterious mutations would eventually be intolerable and lead to cell population meltdown. The tumor population must thus strike a delicate balance to maintain heterogeneity and at the same time curb relentlessly increasing passenger mutations. Exploiting this fact may help develop a new therapeutic regime for cancer (17, 23) . This can be done by either increasing the overall mutation rate (μ) or the deleterious effect of passengers (d). For example, a 10% increase in μ may result in a more than 50% population reduction in 20 days (Fig. S5) . Practically, mutation rate can be increased by targeting the DNA repair system (28) or by regulating DNA replication stress (29) .
However, for these strategies to be effective, an additional layer of cancer biology needs to be considered.
It has been shown by mathematical modeling that a high incidence of defective cells and cell death may not be disadvantageous for tumor growth, but in fact facilitate tumor progression (30) . That is because a high rate of proliferation-reducing or cell death-inducing spontaneous mutation can lead to cancer dynamics that enable sufficient stem-like cell divisions to enrich the pool of cells with high proliferation rate and drive population expansion.
Therapies that directly target cell proliferation should be considered. Since in order to maintain high proliferation rates, rapidly proliferating cells need to increase their translational capacity and are dependent on high rates of ribosome biogenesis (31, 32) . Thus, inhibition of ribosome biogenesis could be a selective approach to cancer therapy (33, 34) . More importantly, this effect is enhanced in cells with higher proliferation rates, but less so in cells with lower proliferation rates.
Materials and Methods
Cell culture and Single cell isolation. bovine serum (FBS) (Gibico, Life Technologies), 100 U/ml of penicillin, and 100 μg/ml of streptomycin at 37º C with 5% CO2. Cells were trypsinized using 0.05% trypsin at room temperature for 3 min. Cell counting was performed with a hemocytometer. The cell suspensions were diluted with medium to the final concentration of 1 cell per 100 µl . Single cells were seeded into each well of a 96-well cell culture plate and maintained at 37º C with 5% CO2. After incubating for 12 hours, during which the cells attached to the wells, the single cell isolation was visually confirmed by microscopy. The number of cells in each well was counted every day. When the cell colony became sufficiently large, cells were transferred to 24-well plates, and subsequently transferred to 6-well plates and 10-cm culture dishes.
Karyotype analysis.
The 
Real-time cell analysis assay (RTCA).
Cells in 10% FBS media were seeded at a density of 5000 per well into a 16-well E-plate (ACEA) and incubated for 72 hours at 37 °C in a humidified CO2 incubator. The impedance for each well was monitored 11 by the RTCA iCELLgence™ system (ACEA Biosciences Inc) every 70 minutes. Relative impedance signal level (represented as "cell index" in manufacturer's software) that indicated the number of cells was analyzed using the RTCA Software 1.2 program (Roche Diagnostics). The cell growth curves were automatically recorded on the iCELLigence system in real time. The cell index was followed for 3 days.
Measurement of growth rate.
The single cell clones that we generated for the growth rate calculation were in the log phase, the period of exponential increase in the cell number. During this phase,
where N(t) is the total number or the concentration of cells at time t, and k is a constant coefficient. To obtain a linear function, the cell numbers were converted to logarithms to the base of Euler's number e. The leastsquares method (LSM) was used to fit the linear regression in which the slope (k) of the regression line would be the growth rate.
Whole genome sequencing and analysis of copy number variation. (Fig S4) . FREEC was run with the following parameters:
window size, 100kb; step size, 50 kb; contaminationAdjustment = TRUE; noisyData = TRUE; BAF calculation inactivated. The segmental copy number gain and lose of each descendant clone was profiled against the E6 genome by preforming the FREEC with the same parameters mentioned above. The relative ratios and breakpoints of copy number gain and lose against the E6 were calculated and identified for the 5 descendant clones (Fig 2A, Table S2 ).
eGFP and DsRed transfection.
Cells with the stable expression of eGFP and DsRed were constructed by transfecting with lentivirus vectors, The proportions of the two cell populations in the mixture were monitored by fluorescent intensity of DsRed and eGFP every 3 days by using flow cytometry.
Modeling population dynamic of cell expansion.
We construct and apply a simple model of cell growth and mutation accumulation process. We define as population size at the day t, where 0 = 1, and as the growth rate of population at day t. In this case, (S1) and −1 are given by a recursive function
Iterating (S2) t times, can be expressed as
where R0 is the growth rate at day 0. Substitute (S3) into (S1) yields:
2 .
(S4)
Since the experiments start from single cell isolation ( 0 = 1), can be derived as
Estimate and fitness reduction . (S8)
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To calculate 0 , we substitute (S7) into (S6). Then 0 can be expressed as 
Inference of R0, and by Approximate Bayesian Computation (ABC).
Due to the complexity of the parameter space, we used Approximate Bayesian Computation (ABC) method by comparing the simulated 10 6 cell lines with observed data with HeLa to estimate 0 , and d. ABC algorithms are a group of methods for performing Bayesian inference without the need for explicit evaluation of the model likelihood function. The algorithms can be used with implicit computer models that generate sample data sets rather than likelihoods (36, 37) . By using ABC we can compute the posterior probability distribution of a multivariate parameter ( = { 0 , , }). A parameter value is sampled from its prior 16 distribution ( ) to simulate a dataset ( ), for i = 1, …, 10 6 . A set of summary statistics, the value that calculated from the data to represent the maximum amount of information in the simplest possible form, ( ) is computed from the simulation. By using a distance function , we calculated the distance between ( ) and observed data . If the distance between ( ) and is less than a given threshold, the parameter value is accepted. In order to set the threshold that which simulations are accepted, we provide the tolerance rate , which is defined as the percentage of accepted simulation (38, 39) .
The ABC inference scheme is:
1. Sample a candidate parameter = { 0 , , } from the prior distribution ( );
2. Simulate the growth process of the cell line and calculate the summary statistics ;
3. Compare the simulated dataset ( ), with the observed data , using a distance function and tolerance rate , if ( ( ), ) < , accept ;
4. Go to 1.
Here the summary statistics ( )= {simulated cell number of 7 days}. The observed summary statistics also Table S2 ). To estimate parameters in equation (1), single cells were randomly chosen from different cancer cell lines and their growth from day 0 to day 7 was monitored. Fitness reduction was evaluated based on the parameters estimated by applying computer simulations, which are described in Results and Methods. 1 The number of single cell clones generated from different cancer cell lines 2 Growth rate of cell population at day 0 3 Deleterious mutation rate 4 Mean deleterious effect of a mutation Table S1 ), 20~30% of cells from each clone were randomly drawn and separated into single cells.
The growth of these cells was monitored for 8 days (time point I, solid boxplots). When cell numbers reached to more than 5000 cells (time point II, blank boxplots), a number of single cell clones (Table S1) were generated, and the cell growth for those clones was monitored again. *: p < 0.05; **: p < 0.01, Wilcoxon test. 1 Single cells were randomly drawn from B8, followed by cell culture for seven days. The cell numbers in the single cell clones were counted every day. According to their cell numbers on the 7 th day, newly derived cell clones are grouped into fast (cell number > 100) and slow (cell number < 100) growing clones. 2 The Approximate Bayesian Computation (ABC) method was performed to estimate R0, u and d for each clone. Using ABC method with the fixed μ (0.29) and d (0.18), R0 was estimated from the cell clones derived from B8 and E3. The expected data were calculated from equation (1) using the estimated R0. Chi-square test was used to test whether the expected data are fitted with the observed data. *, P-value < 0.05; **, P-value < 0.01; ***, P-value < 0.001.
